Investing News NetworkYour trusted source for investing success

allergic conjunctivitis

Aldeyra Therapeutics Shares Financials for Q1 2017

Aldeyra Doses Last Patient in Allergic Conjunctivitis Trial

Tetra Bio-Pharma Enters into Binding Term Sheet for Two Products with Panag Pharma

Ocular Therapeutix™ Announces Successful Topline Results from Phase 3 Clinical Trial of DEXTENZA™

Aldeyra Therapeutics Announces Third Quarter 2016 Financial Results

Ocular Therapeutix Reports Third Quarter 2016 Financial Results and Provides Corporate Update

Nicox Offers Third Quarter 2016 Business Update

Nicox Receives Complete Response from FDA Related for AC-170

Ocular Therapeutix™ Begins Enrollment in First Phase 3 Clinical Trial with OTX-TP

Nicox first half 2016 business and financial update

Ocular Therapeutix™ Announces Presentation at the Ophthalmology Innovation Summit (OIS) at the American Society of Retina Specialists (ASRS)

Operations update with mine production up 25% QoQ

Empire Metals Limited Announces Team Expansion & Bulk Met Testing Commences

Surface Metals: Gold and Lithium Portfolios in North America’s Most Strategic Jurisdictions

SAGA Metals Showcases Radar Project as Potentially Comparable to China's Panzhihua VTM Deposit

Forte Minerals Secures C$5.7 Million Strategic Investment to Advance Alto Ruri Project

Surface Metals

Maritime Resources

Triumph Gold

Quimbaya Gold

New Age Exploration

Asara Resources

MARKETS

COMMODITIES

CURRENCIES